ED
CVIA

Exane Derivatives’s Covia Holdings Corporation Common Stock CVIA Stock Holding History

Exane Derivatives’s Portfolio CVIA Stock Details CVIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19,056
Closed -$358K – 733
2018
Q2 		$358K Buy
+19,056
New +$403K 0.06% 198

Other funds holding CVIA

SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's CVIA Position: Q3 2018 in Review

Exane Derivatives sold out of Covia Holdings Corporation Common Stock (CVIA) in Q3 2018, closing a stake of 19,056 shares — an estimated $358K sold.

Exane Derivatives first reported a position in CVIA in Q2 2018 and held it in 1 quarter. The position peaked at $358K in Q2 2018. 104 funds tracked by Wall St. Rank hold CVIA as of Q3 2018.

  • Exane Derivatives reported no remaining Covia Holdings Corporation Common Stock position as of Q3 2018 after selling out during the quarter.
  • Exane Derivatives sold 19,056 Covia Holdings Corporation Common Stock shares in Q3 2018, an estimated $358K.
  • Exane Derivatives first reported a position in Covia Holdings Corporation Common Stock in Q2 2018 and held it in 1 quarter.
  • Exane Derivatives's Covia Holdings Corporation Common Stock position peaked at $358K in Q2 2018.
  • 104 funds tracked by Wall St. Rank held Covia Holdings Corporation Common Stock as of Q3 2018.

Based on Exane Derivatives's 13F filing for Q3 2018, filed 24 Oct 2018.